Last updated 23 days ago

Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

110 patients around the world
Available in Brazil
AbbVie
2Research sites
110Patients around the world

This study is for people with

Ulcerative colitis
Moderate/severe ulcerative colitis

Requirements for the patient

To 17 Years
All Gender

Medical requirements

Sites

Hospital Pequeno Príncipe
Recruiting
Rua Desembargador Motta, 1070 - Água Verde, Curitiba - PR, 80250-060
Hospital e Maternidade Celso Pierro
Recruiting
Campinas, 13590-900
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy